Dare Bioscience, Inc. Income (Loss) from Continuing Operations before Income Taxes, Domestic
Dare Bioscience, Inc. (DARE) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$13.32 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-26
- Dare Bioscience, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$13.32M.
- Dare Bioscience, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$3.82M.
- Dare Bioscience, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$29.10M.
- Dare Bioscience, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$28.39M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-31 | -$13.32M 10-K · filed 2026-03-26 |
| 2024-12-31 | -$3.82M 10-K · filed 2026-03-26 |
| 2023-12-31 | -$29.10M 10-K · filed 2025-03-31 |
| 2022-12-31 | -$28.39M 10-K · filed 2024-03-28 |
| 2021-12-31 | -$37.08M 10-K · filed 2023-03-30 |
| 2020-12-31 | -$27.25M 10-K · filed 2022-03-31 |
| 2019-12-31 | -$13.80M 10-K · filed 2021-03-30 |
| 2018-12-31 | -$16.71M 10-K · filed 2020-03-27 |
| 2017-12-31 | -$11.50M 10-K · filed 2019-04-01 |
| 2016-12-31 | -$673.00K 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |